Business

October 24, 2011

Celanese Takes An Ethanol Plunge (Member Content)

(October 24, 2011 | Vol. 89 Issue 43 | pp. 20-21)

The chemical producer seeks to make ethanol a major business but is secretive about details of its process.

Building On The Momentum (Member Content)

(October 24, 2011 | Vol. 89 Issue 43 | p. 22)

BWA Water Additives rides crest of rising demand for specialty water treatment chemicals.

European Firms Invest In China

(October 24, 2011 | Vol. 89 Issue 43 | p. 6)

Specialty Chemicals: Companies pursue local research and production.

Investors Bet On Cleantech

(October 24, 2011 | Vol. 89 Issue 43 | p. 9)

Green Chemistry: Close to $1 billion is slated for start-up firms.

October 17, 2011

Emerging Strategies

(October 17, 2011 | Vol. 89 Issue 42 | pp. 15-26)

Faced with change, pharmaceutical firms shift business mix to generics and emerging markets.

A Sense of Urgency (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 30-32)

Call for drug safety pushes the mundane art of supply chain management to the front burner.

Growing Businesses The Scottish Way (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 33-35)

Development authorities seek to harness industry‑academia cooperation in the life sciences.

An Update On Dow (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 36-38)

CEO Andrew N. Liveris believes the major pieces are in place to continue the company's transformation.

AstraZeneca Shifts Operations

(October 17, 2011 | Vol. 89 Issue 42 | p. 10)

Pharmaceuticals: Firm will add manufacturing in China while cutting jobs in the U.S.

Investment Deterrent

(October 17, 2011 | Vol. 89 Issue 42 | p. 11)

Venture capital firms say FDA regulations hamper their support of biopharma companies.

October 10, 2011

When Scientists Betray Employers (Member Content)

(October 10, 2011 | Vol. 89 Issue 41 | pp. 24-26)

Cultural differences may help explain rash of trade secret theft involving Asian researchers.

Solar Shuffle (Member Content)

(October 10, 2011 | Vol. 89 Issue 41 | p. 24)

The U.S. becomes a top destination for installing—but not manufacturing—photovoltaic modules.

Avantor Bolsters Presence In Taiwan (Member Content)

(October 10, 2011 | Vol. 89 Issue 41 | p. 30)

Joining others, electronic materials supplier sets up technical center in key semiconductor market.

Dow Invests In Education

(October 10, 2011 | Vol. 89 Issue 41 | p. 9)

Research: Firm will spend $250 million on chemistry programs at U.S. universities.

Contract Research

(October 10, 2011 | Vol. 89 Issue 41 | p. 11)

Pharmaceutical Product Development to go private in $3.9 billion deal.

Cellulosic Ethanol Production Lags

(October 10, 2011 | Vol. 89 Issue 41 | p. 12)

Biofuels: National Research Council questions government's output goals.

October 3, 2011

Bridging The Gap

(October 3, 2011 | Vol. 89 Issue 40 | pp. 14-19)

As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on.

Adding Electrolytes (Member Content)

(October 3, 2011 | Vol. 89 Issue 40 | pp. 22-23)

New players follow in the footsteps of lithium-ion battery makers to meet surging U.S. demand.

A Media-Savvy Firm (Member Content)

(October 3, 2011 | Vol. 89 Issue 40 | p. 24)

SAFC looks beyond fine chemicals to cell culture media for growth.

Tronox Will Merge With Ore Supplier

(October 3, 2011 | Vol. 89 Issue 40 | p. 7)

Inorganics: Company says Exxaro unit will enable it to expand to meet demand.

Drug Discovery

(October 3, 2011 | Vol. 89 Issue 40 | p. 7)

Expanded initiative will bridge Lilly's internal, philanthropic R&D efforts.

Huntsman Shrinks Its Swiss Presence

(October 3, 2011 | Vol. 89 Issue 40 | p. 8)

Textile Dyes: Industry migration to Asia continue.

September 26, 2011

Getting The Steel Out

(February 8, 2011 | Vol. 89 Issue 6 | pp. 10-14)

Automakers push ahead on energy-saving carbon fiber composites despite questions of economic viability.

Making The Most Of Changes In Printing (Member Content)

(September 26, 2011 | Vol. 89 Issue 39 | pp. 18-19)

New pigment chemistry is a boon for Cabot and a Massachusetts town.

The Public Wins In Dalian (Member Content)

(September 26, 2011 | Vol. 89 Issue 39 | pp. 20-21)

Spontaneous protests lead to closure of a Chinese petrochemical facility.

Ireland Beckons Biotech Business

(September 26, 2011 | Vol. 89 Issue 39 | p. 6)

Pharmaceuticals: Investments and mergers have Irish eyes smiling.

Dow Funds 2012 Chemistry Olympiad

(September 26, 2011 | Vol. 89 Issue 39 | p. 7)

Philanthropy: Firm pledges $2.5 million to help ACS host next year's international competition.

Scientist Admits Trade Secret Theft

(September 26, 2011 | Vol. 89 Issue 39 | p. 7)

Industrial Espionage: Plea deal, if accepted by court, will avoid a trial for former Dow researcher.

Protests Flare At Chinese Solar Plant

(September 26, 2011 | Vol. 89 Issue 39 | p. 8)

Environment: Water contamination infuriates nearby residents.

September 19, 2011

Breaking In The New

(September 19, 2011 | Vol. 89 Issue 38 | pp. 10-14)

Developers of new polymers are trying to avoid the hazards that have made success difficult for many of their predecessors.

Making Aromatics In Singapore (Member Content)

(September 19, 2011 | Vol. 89 Issue 38 | pp. 18-19)

Global consortium is building one of the world's largest p-xylene plants in the city-state.

C&EN Talks With Rodney Banks (Member Content)

(September 19, 2011 | Vol. 89 Issue 38 | p. 20)

Perkin Medal winner says tinkering led to advances in water treatment.

Nanotech Drug Firm Debuts

(September 19, 2011 | Vol. 89 Issue 38 | p. 8)

Alliance: Charitable mission underlies U.K., Russian business.

Sasol's Cajun Country Ventures

(September 19, 2011 | Vol. 89 Issue 38 | p. 9)

South African firm plans to add a multi-billion-dollar gas-to-liquids plant in Louisiana.

September 12, 2011

Peripheral Advances (Member Content)

(September 12, 2011 | Vol. 89 Issue 37 | pp. 14-15)

Chemical companies are experimenting with cutting-edge add-ons to their information technology hubs.

Hello, Chongqing (Member Content)

(September 12, 2011 | Vol. 89 Issue 37 | p. 16)

BASF holds initial meeting with representatives of communities near its southwest China polyurethane project.

Sanofi Outlines New Objectives

(September 12, 2011 | Vol. 89 Issue 37 | p. 8)

Pharmaceuticals: Company plans further cost cutting as it nears a 2012 patent cliff.

Chemical Executives Bullish

(September 12, 2011 | Vol. 89 Issue 37 | p. 9)

With cash on their hands, many executives anticipate M&A increase, survey finds.

September 5, 2011

Covalent Drugs Form Long-Lived Ties

(February 8, 2011 | Vol. 89 Issue 6 | pp. 19-26)

Irreversible inhibitors may provide unique benefits in drug development.

Striving For Secure Supply (Member Content)

(September 5, 2011 | Vol. 89 Issue 36 | pp. 30-33)

Custom manufacturers of controlled substances confront unique challenges in a drug market niche.

Regulations: Agencies Keep Tight Limits On Makers Of Controlled Substances (Member Content)

(September 5, 2011 | Vol. 89 Issue 36 | pp. 30-33)

 

Waters Follows A Narrow Course (Member Content)

(September 5, 2011 | Vol. 89 Issue 36 | pp. 34-37)

Scientific instrument maker vows to stick with the separations and analysis businesses it knows best.

Heat-Seeking Division: TA Instruments Leverages Small Buyouts For Growth (Member Content)

(September 5, 2011 | Vol. 89 Issue 36 | p. 37)

 

Proppant Progress

(September 5, 2011 | Vol. 89 Issue 36 | Web Exclusive)

A workhorse for oil and gas extraction sees material advances amid growing demand.

Pfizer Advances Its Pipeline

(September 5, 2011 | Vol. 89 Issue 36 | p. 12)

Drug Discovery: An approval and key late-stage data restore confidence in the firm's R&D engine.

BioAmber Will Expand Succinic Acid Production

(September 5, 2011 | Vol. 89 Issue 36 | p. 14)

Scale-up: Firm selects Ontario site for intermediate chemical made by fermentation.

August 29, 2011

Homegrown R&D Flowers In China (Member Content)

(August 29, 2011 | Vol. 89 Issue 35 | pp. 18-21)

Seasoned executives foresee big opportunities for innovative drugs for the Chinese market.

A Fall And Rise (Member Content)

(August 29, 2011 | Vol. 89 Issue 35 | pp. 22-24)

Entrepreneurial chemist looks back on companies he built and then lost.

BASF To Invest Big In Brazil

(August 29, 2011 | Vol. 89 Issue 35 | p. 6)

Petrochemicals: Planned facility includes South America's first acrylic acid, superabsorbent polymers plants.

Contract Research

(August 29, 2011 | Vol. 89 Issue 35 | p. 7)

Aptuit will sell clinical-trial supply unit to Catalent

Genomatica To Go Public

(August 29, 2011 | Vol. 89 Issue 35 | p. 8)

Biobased Chemicals: Initial public offering plan follows partnership and new product announcements.

August 22, 2011

Asia Advances Biosimilars (Member Content)

(August 22, 2011 | Vol. 89 Issue 34 | pp. 24-25)

Companies in South Korea, China, and India are scrambling to market generic biopharmaceuticals.

Codexis Undergoes Its Own Evolution (Member Content)

(August 22, 2011 | Vol. 89 Issue 34 | pp. 26-28)

The firm is bringing its biocatalyst engineering to industrial processes beyond pharmaceuticals.

Deals Dwindle (Member Content)

(August 22, 2011 | Vol. 89 Issue 34 | p. 29)

Chemical deal-making has hit a soft patch, though observers say it is probably only temporary.

Cargill Beefs Up Animal Nutrition

(August 22, 2011 | Vol. 89 Issue 34 | p. 8)

Feed Additives: Firm bests chemical maker DSM with deal for Provimi.

Renewable Energy

(August 22, 2011 | Vol. 89 Issue 34 | p. 9)

Two solar panel manufacturers shutter U.S. operations.

Pfizer Wards Off Viagra Challenge

(August 22, 2011 | Vol. 89 Issue 34 | p. 10)

Pharmaceuticals: Ruling protects exclusivity for blockbuster drug until 2019.

August 15, 2011

Earnings Survive Unstable Recovery (Member Content)

(August 15, 2011 | Vol. 89 Issue 33 | pp. 18-20)

Chemical firms' second-quarter results show signs that demand is stagnating.

Pipeline Payoff Helps Pharma (Member Content)

(August 15, 2011 | Vol. 89 Issue 33 | pp. 21-23)

Drug company first-half results were helped by new product launches and emerging-market sales.

Lighting The Way (Member Content)

(August 15, 2011 | Vol. 89 Issue 33 | p. 24)

Former PerkinElmer unit Excelitas pledges to strengthen its ties to the instrumentation industry.

Economic Woes Hit Chemical Makers

(August 15, 2011 | Vol. 89 Issue 33 | p. 5)

Finance: Observers fear the economic soft patch is looking more like another recession.

Pfizer Augments Academic Network

(August 15, 2011 | Vol. 89 Issue 33 | p. 8)

Collaboration: San Diego hosts the drugmaker's latest partnership.

August 8, 2011

Women in Industry (Member Content)

(August 8, 2011 | Vol. 89 Issue 32 | pp. 22-23)

Women show marginal gains in this year’s edition of the C&EN survey of female executives.

Indian Firms Spread Their Wings (Member Content)

(August 8, 2011 | Vol. 89 Issue 32 | pp. 24-27)

Acquisitions of Western assets demonstrate confidence on global stage.

Taking A Big Step In Virtual Space (Member Content)

(August 8, 2011 | Vol. 89 Issue 32 | pp. 28-29)

Schrödinger counts on new investments to help it increase the impact of computational chemistry on drug discovery.

Business Slows In Europe

(August 8, 2011 | Vol. 89 Issue 32 | p. 9)

Chemicals: Second-quarter results are better than last year's, but firms see demand softening.

More Merck Job Cuts

(August 8, 2011 | Vol. 89 Issue 32 | p. 10)

Pharmaceuticals: Drug maker heralds a second round of layoffs despite strong second quarter.

August 1, 2011

BASF Comes To Town (Member Content)

(August 1, 2011 | Vol. 89 Issue 31 | pp. 20-22)

German firm launches charm offensive in China in face of protests over polyurethane project.

Behind The Surge (Member Content)

(August 1, 2011 | Vol. 89 Issue 31 | pp. 23-25)

A swell in FDA approvals has many wondering whether the drug industry has finally gotten better at R&D.

Seeking Efficiency (Member Content)

(August 1, 2011 | Vol. 89 Issue 31 | pp. 26-27)

Energy-saving projects are especially valued by Europe's chemical industry.

Sadara Chemical Venture To Rise

(August 1, 2011 | Vol. 89 Issue 31 | p. 7)

Joint Venture: Construction of $20 billion Dow, Saudi Aramco megaproject is set to begin.

Earnings Strength Continues

(August 1, 2011 | Vol. 89 Issue 31 | p. 11)

Second quarter: Demand, pricing power benefit chemical firms.

Building A "String Of Pearls"

(August 1, 2011 | Vol. 89 Issue 31 | p. 11)

Bristol-Myers Squibb will add Amira Pharmaceuticals to its list of acquisitions.

July 25, 2011

Global Top 50

(July 25, 2011 | Vol. 89 Issue 30 | pp. 12-15)

Chemical producers show surprisingly good profits soon after the recession.

Paying Attention To Manufacturing (Member Content)

(July 25, 2011 | Vol. 89 Issue 30 | pp. 18-22)

Consortia aim to bridge the gap between drug development and manufacturing with a technology and engineering focus.

China Draws Catalyst Suppliers (Member Content)

(July 25, 2011 | Vol. 89 Issue 30 | pp. 24-26)

Technology providers see opportunity as China seeks to make better plastics.

Ecolab To Buy Water Firm Nalco

(July 25, 2011 | Vol. 89 Issue 30 | p. 8)

Specialties: Transaction will create a leader in water treatment and cleaning products.

Sweet Biopolymers Deal

(July 25, 2011 | Vol. 89 Issue 30 | p. 9)

Mitsui & Co., Dow Chemical joint venture in Brazil will be based on sugarcane.

July 18, 2011

Algae Plans Bloom (Member Content)

(July 18, 2011 | Vol. 89 Issue 29 | pp. 19-20)

From personal care to fish food, algae firms look for ways to make profits quickly.

Super Natural Cosmetic Potions (Member Content)

(July 18, 2011 | Vol. 89 Issue 29 | pp. 21-22)

Advances in biotechnology enable a new generation of plant-derived ingredients.

Lifeline Skin Care (Member Content)

(July 18, 2011 | Vol. 89 Issue 29 | pp. 21-22)

Biotech firm adds human cell extracts to cosmetics.

The Long War On Cancer (Member Content)

(July 18, 2011 | Vol. 89 Issue 29 | p. 23)

Decades after the National Cancer Act, scientists are turning to information-rich, early-stage studies to advance oncology.

A New Push Against HIV

(July 18, 2011 | Vol. 89 Issue 29 | p. 8)

Partnering: Merck, Sangamo, and NIH will join universities to combat HIV drug resistance.

Lonza To Buy Arch Chemicals

(July 18, 2011 | Vol. 89 Issue 29 | p. 9)

Specialties: Acquisition will make Lonza a leader in the microbial control market.

Blaming DuPont

(July 18, 2011 | Vol. 89 Issue 29 | p. 9)

Safety board finds the company negligent in a series of accidents, one fatal, in 2010.

July 11, 2011

Electronic Complexity

(July 11, 2011 | Vol. 89 Issue 28 | pp. 9-18)

Materials suppliers must stay on the cutting edge to keep pace with demand for smaller, faster, and brighter electronics.

Bioplastics Gathering (Member Content)

(July 11, 2011 | Vol. 89 Issue 28 | pp. 21-22)

At the first BioPlastek forum, delegates met for an exchange of information and pointed discussion.

De-Risking Business (Member Content)

(July 11, 2011 | Vol. 89 Issue 28 | pp. 23-24)

At BIO, pharma executives pondered how to advance science in a risk-averse environment.

C&EN Talks With Robert Grubbs (Member Content)

(July 11, 2011 | Vol. 89 Issue 28 | p. 25)

Nobel Laureate shares his views on commercializing science developed in an academic lab.

Companies Eye Russian Links

(July 11, 2011 | Vol. 89 Issue 28 | p. 5)

Partnerships: Drug and chemical firms scope out the landscape in a market primed for growth.

Long Grain Rice Suits Settled

(July 11, 2011 | Vol. 89 Issue 28 | p. 6)

Bayer has settled with U.S. farmers over contamination by its modified rice crop.

July 4, 2011

Facts & Figures Of The Chemical Industry

(July 4, 2011 | Vol. 89 Issue 27 | pp. 39-67)

Chemical industry began to witness global economic recovery, seeing increases in production, trade by the end of 2010.

Reset For Fine Chemicals (Member Content)

(July 4, 2011 | Vol. 89 Issue 27 | pp. 14-16)

Attendees at the annual Chemspec Europe exhibition calibrated growth prospects in recuperating markets.

FDA Reaches Out (Member Content)

(July 4, 2011 | Vol. 89 Issue 27 | p. 17)

Agency seeks to pool its limited resources with others to strengthen inspections of drug plants abroad.

C&EN Talks With Jean-Pierre Clamadieu (Member Content)

(July 4, 2011 | Vol. 89 Issue 27 | p. 18)

The chief executive officer of Rhodia is preparing for the day when he will head Solvay.

Pfizer Rethinks Plan For U.K. Site

(July 4, 2011 | Vol. 89 Issue 27 | p. 8)

Pharmaceuticals: Firm keeps some U.K. R&D staff while advancing plans for research park.

BIO Goes To Washington

(July 4, 2011 | Vol. 89 Issue 27 | p. 9)

Biopharmaceuticals: Annual conference focuses on need for regulatory and policy reform.

June 27, 2011

Keeping The Faith At Germany's BASF (Member Content)

(June 27, 2011 | Vol. 89 Issue 26 | pp. 18-21)

Chairman Kurt Bock seeks to balance old and new at the world's largest chemical maker.

Drug Industry Meets In Shanghai

(June 27, 2011 | Vol. 89 Issue 26 | p. 12)

Pharmaceutical Ingredients: Exhibitors at CPhI China note the country's increasing sophistication.

Climate Change

(June 27, 2011 | Vol. 89 Issue 26 | p. 13)

Businesses see opportunity in adaptation, report finds.

DAK Americas Buys Wellman for $185 Million

(June 27, 2011 | Vol. 89 Issue 26 | p. 15)

Plastics: Purchase will make DAK the largest North American maker of polyester resins.

June 20, 2011

After The Break-Up

(June 20, 2011 | Vol. 89 Issue 25 | pp. 15-30)

The end of a partnership with big pharma brings both opportunity and challenge for biotech firms.

An Industry Resurgent (Member Content)

(June 20, 2011 | Vol. 89 Issue 25 | p. 23)

Chemical executives at annual meeting revel in good times, stay wary on regulations.

Clariant Tells Its Story (Member Content)

(June 20, 2011 | Vol. 89 Issue 25 | pp. 24-25)

Company leaders discuss outlook, as well as the Süd-Chemie acquisition, at a London event.

Porton Matures (Member Content)

(June 20, 2011 | Vol. 89 Issue 25 | p. 26)

China-based custom intermediates producer enters active drug ingredients market.

Biotech Sector Rebounds

(June 20, 2011 | Vol. 89 Issue 25 | p. 12)

Pharmaceuticals: Recovery is occurring but growth is slow, dogged by a widening gap in access to capital.

Merck Moves Again On Biosimilars

(June 20, 2011 | Vol. 89 Issue 25 | p. 13)

Pharmaceuticals: Deal with South Korea's Hanwha adds generic version of Amgen's Enbrel to its portfolio.

June 13, 2011

Building Small

(June 13, 2011 | Vol. 89 Issue 24 | pp. 12-17)

Nanotechnology makes inroads in the construction industry.

Degrading Plastics (Member Content)

(June 13, 2011 | Vol. 89 Issue 24 | pp. 20-21)

Makers of oxo-degradable additives say they are addressing the litter problem, but others aren't so sure.

Coal Evolution In China (Member Content)

(June 13, 2011 | Vol. 89 Issue 24 | pp. 22-23)

Chemical production is highlighted at recent catalysis conference in China.

JSR Plans Ahead (Member Content)

(June 13, 2011 | Vol. 89 Issue 24 | p. 25)

The firm aims to compete globally in rubber while developing cutting-edge materials.

Pfizer Expands R&D Network

(June 13, 2011 | Vol. 89 Issue 24 | p. 8)

Partnership: Eight Boston research institutions will form a third regional hub.

New Cracker For Appalachia

(June 13, 2011 | Vol. 89 Issue 24 | p. 9)

Shell's proposed facility will reverse a petrochemicals exodus from the region.

June 6, 2011

BPA Debate

(June 6, 2011 | Vol. 89 Issue 23 | pp. 13-22)

Researchers disagree about potential toxicity of the estrogen mimic bisphenol A.

Stretching Paint Performance (Member Content)

(June 6, 2011 | Vol. 89 Issue 23 | pp. 26-28)

Functional additives push water-based paint into applications that were once unheard of.

Nanoparticles: Research Firm Tries Its Hand At Making Self-Healing Paint (Member Content)

(June 6, 2011 | Vol. 89 Issue 23 | p. 28)

 

Benchtop Informatics (Member Content)

(June 6, 2011 | Vol. 89 Issue 23 | pp. 30-31)

Accelrys is pushing to expand its market with electronic laboratory notebooks.

Urea's Unlikely Role (Member Content)

(June 6, 2011 | Vol. 89 Issue 23 | p. 32)

Emissions reduction is new application for chemical best known as a fertilizer.

Ashland Dives Into Specialties

(June 6, 2011 | Vol. 89 Issue 23 | p. 9)

Acquisitions: Purchase of ISP will sharpen focus on personal care, drug ingredients.

R&D Globalization

(June 6, 2011 | Vol. 89 Issue 23 | p. 9)

Belgium's Solvay teams up with South Korean university.

Clean Technology

(June 6, 2011 | Vol. 89 Issue 23 | p. 11)

Investors latch on to biobased-chemical makers.

May 30, 2011

Peptide Therapeutics

(May 30, 2011 | Vol. 89 Issue 22 | pp. 13-25)

Drug class's stock rises as firms solve the problems of stability, delivery, and manufacture.

Phthalates Face Murky Future (Member Content)

(May 30, 2011 | Vol. 89 Issue 22 | pp. 28-31)

As Europe moves toward a ban on some phthalates, producers of the plasticizers look to diversify.

Indena Steps Up (Member Content)

(May 30, 2011 | Vol. 89 Issue 22 | pp. 32-34)

Extracts and API producer makes its own drug discoveries to keep ahead of competitors.

Rubber Is Booming In Southeast Asia (Member Content)

(May 30, 2011 | Vol. 89 Issue 22 | pp. 35-36)

Elastomer producers set up shop in Singapore and Thailand.

Vertex Hepatitis Drug Is Approved

(May 30, 2011 | Vol. 89 Issue 22 | p. 8)

Pharmaceuticals: Stage is set for a heated competition between Vertex and Merck.

Pharmaceuticals

(May 30, 2011 | Vol. 89 Issue 22 | p. 9)

Lilly creates new company to assume U.S. rights for sepsis drug.

May 23, 2011

Japan Rising

(May 23, 2011 | Vol. 89 Issue 21 | pp. 22-23)

Japan's chemical enterprise is recovering after the devastating earthquake and tsunami.

Spirits Improve In Industrial Biotech (Member Content)

(May 23, 2011 | Vol. 89 Issue 21 | pp. 24-25)

New investments, alliances are signs of life for biobased chemicals.

Dow Reaches Back (Member Content)

(May 23, 2011 | Vol. 89 Issue 21 | p. 26)

Dow Chemical is investing heavily in petrochemicals to shore up its specialty chemical units.

Petronas, SABIC Have Big Plans

(May 23, 2011 | Vol. 89 Issue 21 | p. 8)

Emerging markets: Malaysian refiner, Saudi petrochemical giant eye projects in Asia, Middle East.

Sanofi Licenses Biologic Drug

(May 23, 2011 | Vol. 89 Issue 21 | p. 9)

Firm gets access to candidate treatment for inflammatory diseases being developed by India's Glenmark.

Takeda To Buy Switzerland's Nycomed

(May 23, 2011 | Vol. 89 Issue 21 | p. 11)

Pharmaceuticals: Purchase will take Japanese firm further outside its home market.

Thermo Fisher Bets On Phadia

(May 23, 2011 | Vol. 89 Issue 21 | p. 11)

Diagnostics: Deal gives instrument firm a stake in allergy and autoimmunity testing.

May 16, 2011

Shock To The System

(May 16, 2011 | Vol. 89 Issue 20 | pp. 11-15)

Big questions about drug safety arise in the wake of rampant supply-chain globalizations.

Battle For Europe: API Producers Make Headway In Brussels On Drug Safety Regulations

(May 16, 2011 | Vol. 89 Issue 20 | p. 13)

Price Hikes Lift Chemical Profits (Member Content)

(May 16, 2011 | Vol. 89 Issue 20 | pp. 18-20)

Higher prices and volumes yield strong first‑quarter earnings for chemical makers.

Big Pharma's Pipeline Promise (Member Content)

(May 16, 2011 | Vol. 89 Issue 20 | pp. 22-23)

First-quarter results were steady, but drug companies see better times as new products approach commercialization.

Braskem's Push (Member Content)

(May 16, 2011 | Vol. 89 Issue 20 | pp. 24-25)

Having consolidated the Brazilian petrochemical industry, firm looks to expand in Latin America and the U.S.

Gujarat Readies For Disaster (Member Content)

(May 16, 2011 | Vol. 89 Issue 20 | p. 26)

Indian state beefs up capabilities of emergency response unit.

Alkermes Buys Elan Business

(May 16, 2011 | Vol. 89 Issue 20 | p. 6)

Restructuring: Sale of drug formulation unit enables Elan to focus on neurology.

Japan's Chemical Profits Surge

(May 16, 2011 | Vol. 89 Issue 20 | p. 7)

Annual Results: Earthquake had minimal impact on 2010 results.

DSM, Roquette Invest In Succinic Acid

(May 16, 2011 | Vol. 89 Issue 20 | p. 9)

Industrial Biotech: Companies plan Europe's largest facility for biobased production.

May 9, 2011

The Next Generation In Genome Sequencing

(May 9, 2011 | Vol. 89 Issue 19 | pp. 17-21)

Advances in technology create new challenges in data analysis.

Top 50 U.S. Chemical Producers (Member Content)

(May 9, 2011 | Vol. 89 Issue 19 | pp. 26-29)

With the recession behind it, U.S. chemical industry girds for growth.

Caveats Temper India's Promise (Member Content)

(May 9, 2011 | Vol. 89 Issue 19 | pp. 30-31)

Chemical market grows strongly, but country remains a difficult place to do business.

The New Millipore (Member Content)

(May 9, 2011 | Vol. 89 Issue 19 | p. 32)

Linked to Germany's Merck, laboratory tools maker expects to bolster services for the pharmaceutical industry.

Albemarle To Make Lithium

(May 9, 2011 | Vol. 89 Issue 19 | p. 12)

New Technology: Company claims advance will allow recovery of lithium from Arkansas brine.

Israel's Teva Will Acquire Cephalon

(May 9, 2011 | Vol. 89 Issue 19 | p. 13)

Pharmaceuticals: Generic drug giant to buy top biopharmaceutical firm.

Firm Fined For Chemist's Death

(May 9, 2011 | Vol. 89 Issue 19 | p. 15)

Safety: Sepracor Canada admits lack of lab ventilation in worker fatality case.

May 2, 2011

Storm Over Silicones

(May 2, 2011 | Vol. 89 Issue 18 | pp. 10-13)

Some cosmetic ingredient makers defend cyclic methylsiloxanes as competitors tout substitutes.

A Market Grows, Block By Block (Member Content)

(May 2, 2011 | Vol. 89 Issue 18 | pp. 16-18)

Pharmaceutical building-block business attracts firms from across the globe.

From Lab Bench To Executive Suite (Member Content)

(May 2, 2011 | Vol. 89 Issue 18 | pp. 20-22)

Palladium Medalist Stephanie Burns reflects on her path to the helm of Dow Corning.

Robert D. Hansen: Company Veteran Is Burns's New Number Two (Member Content)

(May 2, 2011 | Vol. 89 Issue 18 | p. 22)

Amgen's Outlook (Member Content)

(May 2, 2011 | Vol. 89 Issue 18 | p. 23)

The big biotech firm specifies how it will expand through 2015.

Pricing Boosts Chemical Earnings

(May 2, 2011 | Vol. 89 Issue 18 | p. 7)

First Quarter: Strong demand helps firms stay far ahead of rising costs.

OCI Bets On Polysilicon

(May 2, 2011 | Vol. 89 Issue 18 | p. 8)

Investment: South Korean firm will build world's largest plant for the ubiquitous material.

April 25, 2011

Top Instrument Firms

(Apr 25, 2011 | Vol. 89 Issue 17 | pp. 13-19)

Mergers and acquisitions alter the landscape in C&EN's ranking of leading analytical and life sciences instrumentation companies.

Parts On Demand

(Apr 25, 2011 | Vol. 89 Issue 17 | pp. 22-23)

Polymer makers are helping additive manufacturing scale up into full parts production.

High Hopes For Cystic Fibrosis (Member Content)

(Apr 25, 2011 | Vol. 89 Issue 17 | pp. 24-25)

Two compounds to treat the underlying cause of the disease are nearing commercialization.

C&EN Talks With: Patrick Gruber (Member Content)

(Apr 25, 2011 | Vol. 89 Issue 17 | p. 26)

Gevo CEO shares lessons learned in the early days of making renewable materials.

Companies Advance Biobased Chemicals

(Apr 25, 2011 | Vol. 89 Issue 17 | p. 8)

Cleantech: Start-ups are poised to harness cellulosic feedstocks.

Pharmaceuticals: Merck And J&J Settle Arthritis Franchise Dispute

(Apr 25, 2011 | Vol. 89 Issue 17 | p. 9)

April 18, 2011

Farm Market

(Apr 18, 2011 | Vol. 89 Issue 16 | pp. 13-17)

Agricultural chemical makers strive to bring to market pesticides with new modes of action, targets.

Firms Target Biomethionine

(Apr 18, 2011 | Vol. 89 Issue 16 | p. 8)

Feed Additives: French and South Korean companies join for new route to amino acid.

Renewable Chemicals

(Apr 18, 2011 | Vol. 89 Issue 16 | p. 9)

OPX collaborates with Dow for biobased acrylic acid.

Rules Of Engagement (Member Content)

(Apr 18, 2011 | Vol. 89 Issue 16 | pp. 21-23)

European companies and universities increasingly join forces for R&D.

Patchwork: Intellectual Property Rights Vary Across Europe

(Apr 18, 2011 | Vol. 89 Issue 16 | Web Exclusive)

Euticals Makes Its Global Move (Member Content)

(Apr 18, 2011 | Vol. 89 Issue 16 | pp. 24-25)

The small Italian pharma chemicals firm harnesses Archimica.

April 11, 2011

Petrochemicals Rise Again (Member Content)

(Apr 11, 2011 | Vol. 89 Issue 15 | pp. 22-23)

Strong Asian growth has reinvigorated the global petrochemical industry.

China: New Report Describes Continued Petrochemical Expansion (Member Content)

(Apr 11, 2011 | Vol. 89 Issue 15 | pp. 22-23)

 

Signed, Sealed, Stored, Delivered (Member Content)

(Apr 11, 2011 | Vol. 89 Issue 15 | pp. 24-25)

BioFocus is pioneering the compound management business.

Pipeline Pitfalls (Member Content)

(Apr 11, 2011 | Vol. 89 Issue 15 | p. 26)

Big pharma's R&D revamping is hitting biotech company partners.

Solvay To Buy France's Rhodia

(Apr 11, 2011 | Vol. 89 Issue 15 | p. 9)

Specialty Chemicals: $4.8 billion acquisition will create a global powerhouse.

Merck Boosts Eye Care Business

(Apr 11, 2011 | Vol. 89 Issue 15 | p. 11)

Deal to acquire Inspire Pharmaceuticals underscores specialties merger activity.

April 4, 2011

Pittcon 2011

(Apr 4, 2011 | Vol. 89 Issue 14 | pp. 37-40, 41-42, 43-46)

Year of recovery brings increases in conference attendance, mergers and acquisitions, and instrumentation sales.

Keeping Business Eyes On The Prize (Member Content)

(Apr 4, 2011 | Vol. 89 Issue 14 | pp. 18-20)

Small firms making boron reagents compete to supply materials for popular coupling reaction.

Petrochemicals' U.S. Growth Spurt

(Apr 4, 2011 | Vol. 89 Issue 14 | p. 12)

Investment: Two large projects are considered to take advantage of cheap natural gas.

Japan's Industry Stands Strong

(Apr 4, 2011 | Vol. 89 Issue 14 | p. 14)

Natural Disaster: Many firms resume operations as buyers make supply chain adjustments.

March 28, 2011

Hope For The Bees (Member Content)

(Mar 28, 2011 | Vol. 89 Issue 13 | pp. 24-26)

Colony collapse disorder and resistant pests create demand for new treatments.

Malaysia Joins Biotech Bandwagon (Member Content)

(Mar 28, 2011 | Vol. 89 Issue 13 | p. 28)

Country aims to attract manufacturers with smart policies, access to biomass.

Cephalon Agrees To Buy Gemin X

(Mar 28, 2011 | Vol. 89 Issue 13 | p. 9)

Company moves to bolster pipeline with biotech purchase that brings small molecule cancer drugs.

Methyl Isocyanate

(Mar 28, 2011 | Vol. 89 Issue 13 | p. 10)

Bayer ends use of infamous chemical at West Virginia plant.

March 21, 2011

Pharma Outsourcing

(Mar 21, 2011 | Vol. 89 Issue 12 | pp. 15-21)

Successful chemistry outsourcing service providers bring an intellectual contribution to the projects they carry out for their drug company partners.

Rhodia Invests In Synthetic Sandalwood (Member Content)

(Mar 21, 2011 | Vol. 89 Issue 12 | pp. 24-27)

French firm's integration of two manufacturing sites in China should boost competitiveness.

Searching For Gold (Member Content)

(Mar 21, 2011 | Vol. 89 Issue 12 | pp. 26-27)

Instrument maker develops near-infrared analyzers to monitor mined ores.

C&EN Talks With Keith Yamamoto (Member Content)

(Mar 21, 2011 | Vol. 89 Issue 12 | p. 28)

The UCSF vice dean believes universities need to be more active in finding creative partnerships with big pharma.

Japan Fights For Its Rising Sun

(Mar 21, 2011 | Vol. 89 Issue 12 | pp. 8-9)

Natural Disaster: Frontline reports from the country's chemical enterprise underscore the scope of the tragedy, hopes for recovery.

Upbeat Outlook At Pittcon

(Mar 21, 2011 | Vol. 89 Issue 12 | p. 10)

Instrumentation: Firms expand offerings as consolidation trend continues.

Berkshire Hathaway To Buy Lubrizol

(Mar 21, 2011 | Vol. 89 Issue 12 | p. 11)

Deal Making: Warren Buffett's holding company takes a shine to chemicals.

March 14, 2011

Transformed DSM Targets Growth (Member Content)

(Mar 14, 2011 | Vol. 89 Issue 11 | pp. 24-27)

After restructuring, CEO Feike Sijbesma has a four-pronged strategy for expansion.

Stem Cell Surge (Member Content)

(Mar 14, 2011 | Vol. 89 Issue 11 | pp. 28-29)

China Outlines Path Forward

(Mar 14, 2011 | Vol. 89 Issue 11 | p. 10)

People's Congress: Business leaders see opportunity in country's next five-year plan.

Gates Foundation Backs Liquidia

(Mar 14, 2011 | Vol. 89 Issue 11 | p. 11)

Philanthropy makes its first biotech equity investment.

Crop Protection

(Mar 14, 2011 | Vol. 89 Issue 11 | p. 13)

India's Jubilant to commercialize new route to key insecticide intermediate.

March 7, 2011

Petrochemicals (Member Content)

(Mar 7, 2011 | Vol. 89 Issue 10 | pp. 22-25)

Cheap raw materials and a muted industry downturn add up to good times for U.S. companies.

Catching Winners (Member Content)

(Mar 7, 2011 | Vol. 89 Issue 10 | pp. 26-27)

Lilly's online drug discovery initiative reaches its first collaborative deal with the University of Notre Dame.

Integrating Cognis (Member Content)

(Mar 7, 2011 | Vol. 89 Issue 10 | pp. 28-29)

To succeed in personal care, BASF looks to link the scientific and the emotional.

C&EN Talks With J. Brian Ferguson (Member Content)

(Mar 7, 2011 | Vol. 89 Issue 10 | p. 30)

The Chemical Industry Medal Winner navigated Eastman Chemical through a difficult period.

Europe's Firms Back On Track

(Mar 7, 2011 | Vol. 89 Issue 10 | p. 7)

Chemical Earnings: Economic growth powers fourth-quarter rebound.

Merck Sells Biomanufacturing Network To Fujifilm

(Mar 7, 2011 | Vol. 89 Issue 10 | p. 9)

Biopharmaceuticals: Contract manufacturing operations to transfer to industry newcomer.

Daiichi Will Buy Plexxikon

(Mar 7, 2011 | Vol. 89 Issue 10 | p. 10)

Pharmaceuticals: Deal adds to spending spree by Japan's drugmakers.

February 28, 2011

Rebuilding The Supply Chain (Member Content)

(Feb 28, 2011 | Vol. 89 Issue 09 | pp. 28-31)

At Informex, suppliers worked to create new and stronger ties with customers.

Green Chemistry: Pharmaceutical Roundtable Shares Assessment Tool With Suppliers (Member Content)

(Feb 28, 2011 | Vol. 89 Issue 09 | pp. 30-31)

 

Chemical Earnings Gain Steam (Member Content)

(Feb 28, 2011 | Vol. 89 Issue 09 | pp. 32-34)

As the economy heats up, demand for chemicals spreads to all regions and sectors.

Pharma's Next Transformation (Member Content)

(Feb 28, 2011 | Vol. 89 Issue 09 | pp. 36-38)

Companies continued to overhaul R&D amid tepid fourth-quarter results.

Little-Known HEC Beefs Up R&D (Member Content)

(Feb 28, 2011 | Vol. 89 Issue 09 | pp. 40-41)

From 26 scientists in 2005, Chinese drug firm expects its research payroll to hit 1,500 by next year.

Assessing The Cost Of Greenhouse Gases

(Feb 28, 2011 | Vol. 89 Issue 09 | p. 43)

Climate Change: Two studies try to measure long-term impact on business and investors.

Scripps Changes Leadership

(Feb 28, 2011 | Vol. 89 Issue 09 | p. 8)

Biomedical Research: Richard Lerner will step down as president to be succeeded by Berkeley chemist Michael Marletta.

Takeda Splurges On Research

(Feb 28, 2011 | Vol. 89 Issue 09 | p. 8)

Pharma R&D: Japanese firm opens $1.8 billion center.

Gilead Sciences To Buy Calistoga Pharmaceutical

(Feb 28, 2011 | Vol. 89 Issue 09 | p. 9)

Acquisitions: Deal adds key oncology compound to acquisitive firm's pipeline.

Poor Management Led To BP Spill

(Feb 28, 2011 | Vol. 89 Issue 09 | p. 11)

Technical Findings: Long-running problems caused Gulf spill, commission finds.

February 21, 2011

Big Pharma's Last Shot

(Feb 21, 2011 | Vol. 89 Issue 08 | pp. 12-16)

Firms hope they can overcome decadelong drop in productivity through efficient innovation.

Priming The Pump (Member Content)

(Feb 21, 2011 | Vol. 89 Issue 08 | pp. 19-22)

The recession behind them, chemical firms plan healthy increases in R&D and capital spending this year.

Merger Market Thaws (Member Content)

(Feb 21, 2011 | Vol. 89 Issue 08 | pp. 23-24)

More credit and a high interest in fertilizers spurred chemical acquisitions in 2010.

Electrifying Mobility (Member Content)

(Feb 21, 2011 | Vol. 89 Issue 08 | p. 25)

With help from German government, BASF pursues new battery technologies.

Sanofi, Genzyme Come To Terms

(Feb 21, 2011 | Vol. 89 Issue 08 | p. 9)

Acquisitions: For $20 billion, French firm nets a biologics pipeline.

Clariant To Buy Süd-Chemie

(Feb 21, 2011 | Vol. 89 Issue 08 | p. 10)

Specialties: Swiss firm makes its first big move after period of downsizing.

Biobased Chemical Deals Abound

(Feb 21, 2011 | Vol. 89 Issue 08 | p. 11)

Green Chemistry: Customers, investors, and technology firms link up for renewables production.

February 14, 2011

Building Innovation (Member Content)

(Feb 14, 2011 | Vol. 89 Issue 07 | pp. 20-22)

After downsizing, Clariant looks to a new R&D center to help spur product development.

Fighting For Manufacturing (Member Content)

(Feb 14, 2011 | Vol. 89 Issue 07 | p. 23)

Insights: A recent book from Dow's CEO warns about the decline of American manufacturing and offers remedies.

Danaher Will Buy Beckman Coulter

(Feb 14, 2011 | Vol. 89 Issue 07 | p. 6)

Diagnostics: $6.8 billion acquisition expands Danaher's move into life sciences.

Corporate Espionage

(Feb 14, 2011 | Vol. 89 Issue 07 | p. 7)

Former Dow employee is found guilty of stealing trade secrets.

Sunny Outlook At Informex

(Feb 14, 2011 | Vol. 89 Issue 07 | p. 8)

Fine Chemicals: Companies at custom chemicals trade show express optimism, reveal investments.

February 7, 2011

Turning Around Polyester Resin (Member Content)

(Feb 7, 2011 | Vol. 89 Issue 06 | pp. 18-19)

Polyethylene terephthalate producers hope consolidation will improve the market.

A Clean Break (Member Content)

(Feb 7, 2011 | Vol. 89 Issue 06 | p. 20)

Home care ingredients industry regains its stride after the recession.

Pfizer Reveals More R&D Cuts

(Feb 7, 2011 | Vol. 89 Issue 06 | p. 5)

Pharma Jobs: Firm will close its Sandwich, England, site and exit several research areas.

Cytec Sells Basics Unit To Private Equity Firm

(Feb 7, 2011 | Vol. 89 Issue 06 | p. 7)

Acquisition: H.I.G. Capital adds another chemical business to its portfolio.

January 31, 2011

Custom Chemicals

(Jan 31, 2011 | Vol. 89 Issue 05 | pp. 13-19)

Slowly recovering in 2010, contract manufacturers envision a path toward growth by responding to marketplace shifts.

Fulfilling Capacity

(Jan 31, 2011 | Vol. 89 Issue 05 | pp. 21-26)

Despite industry-wide consolidation, pharmaceutical companies continue to offer contract manufacturing.

RNAi Growing Pains (Member Content)

(Jan 31, 2011 | Vol. 89 Issue 05 | pp. 30-33)

Roche's exit cast a pall, but others claim progress in developing RNAi-based drugs.

Cleaning Up (Member Content)

(Jan 31, 2011 | Vol. 89 Issue 05 | pp. 34-36)

Chemical companies face challenges in repairing legacy chemical sites.

Pharma Firms Clinch Deals In Oncology

(Jan 31, 2011 | Vol. 89 Issue 05 | p. 8)

Acquisitions: Purchases add to Amgen's product pipeline and expand diagnostics at Novartis.

Year Ends On High Note

(Jan 31, 2011 | Vol. 89 Issue 05 | p. 9)

Fourth Quarter: Chemical industry reports strong 2010 sales and earnings powered by economic recovery.

January 24, 2011

Using Pore Power (Member Content)

(Jan 24, 2011 | Vol. 89 Issue 04 | pp. 20-21)

New zeolite technologies help refiners crack crude and trucks clean up emissions.

Stimulus Program Underwhelms (Member Content)

(Jan 24, 2011 | Vol. 89 Issue 04 | p. 22)

Small pharma firms cite government's glaring underestimation of the response to a $1 billion program.

Big Pharma Goes Back To School

(Jan 24, 2011 | Vol. 89 Issue 04 | p. 8)

Partnerships: Sanofi, Johnson & Johnson are latest firms to ink research pacts.

GlaxoSmithKline Take A Big Hit

(Jan 24, 2011 | Vol. 89 Issue 04 | p. 9)

Firm announces $3.5 billion charge to cover lawsuits, investigation of marketing practices.

January 17, 2011

Ethylene From Methane (Member Content)

(Jan 17, 2011 | Vol. 89 Issue 03 | pp. 20-21)

Researchers take a new look at an old problem.

Concentrating On Chemistry (Member Content)

(Jan 17, 2011 | Vol. 89 Issue 03 | p. 23)

Contract pharmaceutical chemicals maker CiVentiChem enjoys steady growth in the U.S. and India.

DuPont Snaps Up Danisco

(Jan 17, 2011 | Vol. 89 Issue 03 | p. 7)

Industrial Biotech: $6.3 billion deal will strengthen DuPont's business in alternative fuels and food ingredients.

Merck Will Revamp Former Schering-Plough Headquarters

(Jan 17, 2011 | Vol. 89 Issue 03 | p. 9)

Pharmaceuticals: Shift of biotech research to Kenilworth will result in 580 manufacturing job cuts.

Drug Companies Poised For Growth

(Jan 17, 2011 | Vol. 89 Issue 03 | p. 11)

Outlook: Firms at J. P. Morgan conference shift conversation from restructuring to results.

January 10, 2011

World Chemical Outlook

(Jan 10, 2011 | Vol. 89 Issue 02 | pp. 9-17)

In 2011, the chemical industry will continue its climb out of the recessionary trough.

Printing The Right Connections (Member Content)

(Jan 10, 2011 | Vol. 89 Issue 02 | pp. 20-21)

More than a decade after coming to market, printed electronics have yet to make a big impact.

The Drug Refinery (Member Content)

(Jan 10, 2011 | Vol. 89 Issue 02 | pp. 22-23)

Trevena uses 'biased ligands' to fine-tune the effect of drugs on g-protein-coupled receptors.

Drug Approvals Declined In 2010

(Jan 10, 2011 | Vol. 89 Issue 02 | p. 5)

Regulation: Industry faced tough FDA scrutiny of new products.

Biobased Chemicals Myriant To Build Succinic Acid Plant In Louisiana

(Jan 10, 2011 | Vol. 89 Issue 02 | p. 7)

January 3, 2011

The Dark Side Of Indian Drug-Making (Member Content)

(Jan 3, 2011 | Vol. 89 Issue 01 | pp. 13-14)

Major production base for pharmaceutical ingredients remains heavily contaminated.

Company Of The Year

(Jan 3, 2011 | Vol. 89 Issue 01 | p. 15)

The slow and steady professionalism of BASF makes it this year's choice.

DSM Continues Portfolio Shift

(Jan 3, 2011 | Vol. 89 Issue 01 | p. 8)

Life Sciences: Dutch firm strikes deals in nutrition, antibiotics.

Pharmaceuticals: Eyeing New Market, Novartis will invest $500 million in Russia.

(Jan 3, 2011 | Vol. 89 Issue 01 | p. 8)